这是一篇来自已证抗体库的有关人类 LDLR的综述,是根据34篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合LDLR 抗体。
LDLR 同义词: FHC; LDLCQ2; low-density lipoprotein receptor; LDL receptor; low-density lipoprotein receptor class A domain-containing protein 3

艾博抗(上海)贸易有限公司
兔 单克隆(EP1553Y)
  • 免疫印迹; 小鼠; 图 3a
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, ab52818)被用于被用于免疫印迹在小鼠样本上 (图 3a). Mol Metab (2018) ncbi
兔 单克隆(EP1553Y)
  • 免疫印迹; 小鼠; 图 s5d
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, ab52818)被用于被用于免疫印迹在小鼠样本上 (图 s5d). PLoS Genet (2017) ncbi
兔 单克隆(EP1553Y)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 4d
  • 免疫印迹; 人类; 图 4c
艾博抗(上海)贸易有限公司 LDLR抗体(abcam, ab52818)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 4d) 和 被用于免疫印迹在人类样本上 (图 4c). Oncogene (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 1e
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, ab30532)被用于被用于免疫印迹在小鼠样本上 (图 1e). Sci Rep (2017) ncbi
兔 单克隆(EP1553Y)
  • 免疫印迹; 人类; 1:4000; 图 s1a
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, EP1553Y)被用于被用于免疫印迹在人类样本上浓度为1:4000 (图 s1a). PLoS ONE (2017) ncbi
小鼠 单克隆(1B10H10)
  • 流式细胞仪; 人类; 图 3g
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, ab204941)被用于被用于流式细胞仪在人类样本上 (图 3g). ACS Nano (2017) ncbi
兔 单克隆(EP1553Y)
  • 免疫印迹; 小鼠; 1:1000; 图 3
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, AB52818)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3). Microbes Infect (2016) ncbi
兔 单克隆(EP1553Y)
  • 免疫组化基因敲除验证; 小鼠; 1:1000; 图 4
  • 免疫印迹基因敲除验证; 小鼠; 1:1000; 图 2
  • 免疫组化-冰冻切片; 小鼠; 1:1000; 图 6
艾博抗(上海)贸易有限公司 LDLR抗体(Novus Biologicals, EP1553Y)被用于被用于免疫组化基因敲除验证在小鼠样本上浓度为1:1000 (图 4), 被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:1000 (图 2) 和 被用于免疫组化-冰冻切片在小鼠样本上浓度为1:1000 (图 6). J Lipid Res (2016) ncbi
兔 单克隆(EP1553Y)
  • 免疫印迹; 人类; 1:4000; 图 2
艾博抗(上海)贸易有限公司 LDLR抗体(Epitomics, EP1553Y)被用于被用于免疫印迹在人类样本上浓度为1:4000 (图 2). J Biol Chem (2016) ncbi
兔 单克隆(EP1553Y)
  • 免疫印迹; 人类; 图 3
艾博抗(上海)贸易有限公司 LDLR抗体(abcam, ab52818)被用于被用于免疫印迹在人类样本上 (图 3). BMC Cancer (2015) ncbi
兔 单克隆(EP1553Y)
  • 免疫印迹; 小鼠; 图 7B
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, ab52818)被用于被用于免疫印迹在小鼠样本上 (图 7B). Sci Rep (2015) ncbi
兔 单克隆(EP1553Y)
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, ab52818)被用于被用于免疫印迹在人类样本上. Sci Rep (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, ab30532)被用于被用于免疫印迹在人类样本上浓度为1:1000. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, ab30532)被用于被用于免疫印迹在人类样本上. J Biol Chem (2014) ncbi
兔 单克隆(EP1553Y)
  • 免疫印迹基因敲除验证; 猪; 图 2
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, EP1553Y)被用于被用于免疫印迹基因敲除验证在猪样本上 (图 2). PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, ab30532)被用于被用于免疫印迹在人类样本上. Biochim Biophys Acta (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, ab30532)被用于被用于免疫印迹在大鼠样本上. Neuropsychopharmacology (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500
艾博抗(上海)贸易有限公司 LDLR抗体(Abcam, ab30532)被用于被用于免疫印迹在大鼠样本上浓度为1:500. Genes Nutr (2013) ncbi
安迪生物R&D
山羊 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3c
安迪生物R&D LDLR抗体(R&D Systems, AF2148)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). J Cell Sci (2019) ncbi
山羊 多克隆
  • 免疫印迹; 人类; 1:2000; 图 5A
安迪生物R&D LDLR抗体(R&D, AF2148)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 5A). PLoS ONE (2016) ncbi
山羊 多克隆
  • 免疫印迹; 人类; 1:1000; 图 1
安迪生物R&D LDLR抗体(R&D Systems, AF2148)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). PLoS ONE (2016) ncbi
山羊 多克隆
  • 免疫细胞化学; 人类; 3 ug/ml; 图 s1
安迪生物R&D LDLR抗体(R&D systems, BAF2148)被用于被用于免疫细胞化学在人类样本上浓度为3 ug/ml (图 s1). PLoS ONE (2016) ncbi
小鼠 单克隆(472413)
  • 流式细胞仪; 人类; 图 1
安迪生物R&D LDLR抗体(R&D systems, FAB2148P)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2016) ncbi
山羊 多克隆
  • 免疫印迹; 人类; 图 2
安迪生物R&D LDLR抗体(R&D systems, AF2148)被用于被用于免疫印迹在人类样本上 (图 2). PLoS ONE (2016) ncbi
小鼠 单克隆(472413)
  • 流式细胞仪; 人类; 1:20; 图 4
安迪生物R&D LDLR抗体(R&D Systems, FAB2148P)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 4). PLoS ONE (2015) ncbi
山羊 多克隆
  • 免疫印迹; 人类
安迪生物R&D LDLR抗体(R&D Systems, AF2148)被用于被用于免疫印迹在人类样本上. Eur J Med Chem (2015) ncbi
山羊 多克隆
  • 抑制或激活实验; 人类
安迪生物R&D LDLR抗体(R&D Systems, AF2148)被用于被用于抑制或激活实验在人类样本上. J Virol (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(C7)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 LDLR抗体(Santa Cruz, sc-18823)被用于被用于免疫印迹在人类样本上 (图 1). Cell Death Dis (2015) ncbi
小鼠 单克隆(C7)
  • 免疫印迹; 人类; 图 4a
圣克鲁斯生物技术 LDLR抗体(Santa Cruz, sc-18823)被用于被用于免疫印迹在人类样本上 (图 4a). Nat Med (2015) ncbi
小鼠 单克隆(C7)
  • proximity ligation assay; 人类; 图 13
  • 免疫细胞化学; 人类; 1:20; 图 2a
圣克鲁斯生物技术 LDLR抗体(Santa Cruz, C7)被用于被用于proximity ligation assay在人类样本上 (图 13) 和 被用于免疫细胞化学在人类样本上浓度为1:20 (图 2a). J Biol Chem (2015) ncbi
北京义翘神州
兔 单克隆(301)
  • 流式细胞仪; 人类; 图 1
北京义翘神州 LDLR抗体(SinoBiologicals, 10231-R3031-P)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2016) ncbi
亚诺法生技股份有限公司
兔 多克隆
  • 免疫细胞化学; 小鼠; 1:200; 图 3
  • 免疫印迹; 小鼠; 1:1000; 图 2
亚诺法生技股份有限公司 LDLR抗体(Abnova, PAB8804)被用于被用于免疫细胞化学在小鼠样本上浓度为1:200 (图 3) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2). Nat Commun (2016) ncbi
武汉三鹰
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 3
武汉三鹰 LDLR抗体(proteintech, 10785-1-AP)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3). Lipids Health Dis (2016) ncbi
LifeSpan Biosciences
兔 多克隆
  • 免疫印迹; 牛; 1:500; 图 5
LifeSpan Biosciences LDLR抗体(LSBio, LS-C146979)被用于被用于免疫印迹在牛样本上浓度为1:500 (图 5). Biol Reprod (2015) ncbi
默克密理博中国
小鼠 单克隆
  • 免疫印迹; 牛; 1:100; 图 1c
默克密理博中国 LDLR抗体(Millipore, LP02)被用于被用于免疫印迹在牛样本上浓度为1:100 (图 1c). Reprod Fertil Dev (2017) ncbi
小鼠 单克隆(C7)
  • 免疫印迹; 人类; 图 2b
默克密理博中国 LDLR抗体(Millipore, C7)被用于被用于免疫印迹在人类样本上 (图 2b). PLoS ONE (2015) ncbi
文章列表
  1. Volkmar N, Thezenas M, Louie S, Juszkiewicz S, Nomura D, Hegde R, et al. The ER membrane protein complex promotes biogenesis of sterol-related enzymes maintaining cholesterol homeostasis. J Cell Sci. 2019;132: pubmed 出版商
  2. Zhu L, Shi J, Luu T, Neuman J, Trefts E, Yu S, et al. Hepatocyte estrogen receptor alpha mediates estrogen action to promote reverse cholesterol transport during Western-type diet feeding. Mol Metab. 2018;8:106-116 pubmed 出版商
  3. Rocchi A, Yamamoto S, Ting T, Fan Y, SADLEIR K, Wang Y, et al. A Becn1 mutation mediates hyperactive autophagic sequestration of amyloid oligomers and improved cognition in Alzheimer's disease. PLoS Genet. 2017;13:e1006962 pubmed 出版商
  4. Gallagher E, Zelenko Z, Neel B, Antoniou I, Rajan L, Kase N, et al. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia. Oncogene. 2017;36:6462-6471 pubmed 出版商
  5. Vienken H, Mabrouki N, Grabau K, Claas R, Rudowski A, Schömel N, et al. Characterization of cholesterol homeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts reveals a Niemann-Pick disease type C-like phenotype with enhanced lysosomal Ca2+ storage. Sci Rep. 2017;7:43575 pubmed 出版商
  6. Cook E, Nelson J, Sorrentino V, Koenis D, Moeton M, Scheij S, et al. Identification of the ER-resident E3 ubiquitin ligase RNF145 as a novel LXR-regulated gene. PLoS ONE. 2017;12:e0172721 pubmed 出版商
  7. Lara S, Alnasser F, Polo E, Garry D, Lo Giudice M, Hristov D, et al. Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles. ACS Nano. 2017;11:1884-1893 pubmed 出版商
  8. Fan J, Zareyan S, Zhao W, Shimizu Y, Pfeifer T, Tak J, et al. Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes. PLoS ONE. 2016;11:e0162384 pubmed 出版商
  9. Zhou J, Gao S, Chen J, Zhao R, Yang X. Maternal sodium butyrate supplement elevates the lipolysis in adipose tissue and leads to lipid accumulation in offspring liver of weaning-age rats. Lipids Health Dis. 2016;15:119 pubmed 出版商
  10. Zhao D, Lizardo K, Cui M, Ambadipudi K, Lora J, Jelicks L, et al. Antagonistic effect of atorvastatin on high fat diet induced survival during acute Chagas disease. Microbes Infect. 2016;18:675-686 pubmed 出版商
  11. Poirier S, Hamouda H, Villeneuve L, Demers A, Mayer G. Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain. PLoS ONE. 2016;11:e0157230 pubmed 出版商
  12. Horihata K, Yoshioka S, Sano M, Yamamoto Y, Kimura K, Skarzynski D, et al. Expressions of lipoprotein receptors and cholesterol efflux regulatory proteins during luteolysis in bovine corpus luteum. Reprod Fertil Dev. 2017;29:1280-1286 pubmed 出版商
  13. Topchiy E, Cirstea M, Kong H, Boyd J, Wang Y, Russell J, et al. Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor. PLoS ONE. 2016;11:e0155030 pubmed 出版商
  14. Ramanathan A, Gusarova V, Stahl N, Gurnett Bander A, Kyratsous C. Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes. PLoS ONE. 2016;11:e0154498 pubmed 出版商
  15. Tao W, Moore R, Meng Y, Smith E, Xu X. Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol. J Lipid Res. 2016;57:809-17 pubmed 出版商
  16. Bartuzi P, Billadeau D, Favier R, Rong S, Dekker D, Fedoseienko A, et al. CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL. Nat Commun. 2016;7:10961 pubmed 出版商
  17. Nelson J, Cook E, Loregger A, Hoeksema M, Scheij S, Kovacevic I, et al. Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake. J Biol Chem. 2016;291:4813-25 pubmed 出版商
  18. Laezza C, D Alessandro A, Di Croce L, Picardi P, Ciaglia E, Pisanti S, et al. p53 regulates the mevalonate pathway in human glioblastoma multiforme. Cell Death Dis. 2015;6:e1909 pubmed 出版商
  19. Goedeke L, Rotllan N, Canfrán Duque A, Aranda J, Ramírez C, Araldi E, et al. MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels. Nat Med. 2015;21:1280-9 pubmed 出版商
  20. Ochiai A, Miyata S, Shimizu M, Inoue J, Sato R. Piperine Induces Hepatic Low-Density Lipoprotein Receptor Expression through Proteolytic Activation of Sterol Regulatory Element-Binding Proteins. PLoS ONE. 2015;10:e0139799 pubmed 出版商
  21. Le Q, Blanchet M, Seidah N, Labonté P. Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9. J Biol Chem. 2015;290:23385-400 pubmed 出版商
  22. Mercer J, Argus J, Crabtree D, KEENAN M, Wilks M, Chi J, et al. Modulation of PICALM Levels Perturbs Cellular Cholesterol Homeostasis. PLoS ONE. 2015;10:e0129776 pubmed 出版商
  23. De Gonzalo Calvo D, López Vilaró L, Nasarre L, Pérez Olabarría M, Vázquez T, Escuin D, et al. Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: a molecular and clinicopathological study. BMC Cancer. 2015;15:460 pubmed 出版商
  24. Zhong C, Sun W, Ma Y, Zhu H, Yang P, Wei H, et al. Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice. Sci Rep. 2015;5:10512 pubmed 出版商
  25. Bowdridge E, Goravanahally M, Inskeep E, Flores J. Activation of Adenosine Monophosphate-Activated Protein Kinase Is an Additional Mechanism That Participates in Mediating Inhibitory Actions of Prostaglandin F2Alpha in Mature, but Not Developing, Bovine Corpora Lutea. Biol Reprod. 2015;93:7 pubmed 出版商
  26. Stöhr R, Mavilio M, Marino A, Casagrande V, Kappel B, Möllmann J, et al. ITCH modulates SIRT6 and SREBP2 to influence lipid metabolism and atherosclerosis in ApoE null mice. Sci Rep. 2015;5:9023 pubmed 出版商
  27. Alghamdi R, O Reilly P, Lu C, Gomes J, Lagace T, Basak A. LDL-R promoting activity of peptides derived from human PCSK9 catalytic domain (153-421): design, synthesis and biochemical evaluation. Eur J Med Chem. 2015;92:890-907 pubmed 出版商
  28. Segatto M, Trapani L, Di Tunno I, Sticozzi C, Valacchi G, Hayek J, et al. Cholesterol metabolism is altered in Rett syndrome: a study on plasma and primary cultured fibroblasts derived from patients. PLoS ONE. 2014;9:e104834 pubmed 出版商
  29. Pedersen N, Wang S, Narimatsu Y, Yang Z, Halim A, Schjoldager K, et al. Low density lipoprotein receptor class A repeats are O-glycosylated in linker regions. J Biol Chem. 2014;289:17312-24 pubmed 出版商
  30. Davis B, Wang X, Rohret J, Struzynski J, Merricks E, Bellinger D, et al. Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs. PLoS ONE. 2014;9:e93457 pubmed 出版商
  31. Cai K, Lucki N, Sewer M. Silencing diacylglycerol kinase-theta expression reduces steroid hormone biosynthesis and cholesterol metabolism in human adrenocortical cells. Biochim Biophys Acta. 2014;1841:552-62 pubmed 出版商
  32. Prentoe J, Serre S, Ramírez S, Nicosia A, Gottwein J, Bukh J. Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus. J Virol. 2014;88:1725-39 pubmed 出版商
  33. Segatto M, Manduca A, Lecis C, Rosso P, Jozwiak A, Swiezewska E, et al. Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats. Neuropsychopharmacology. 2014;39:841-54 pubmed 出版商
  34. Boschetti E, Di Nunzio M, Danesi F, Tugnoli V, Bordoni A. Influence of genotype on the modulation of gene and protein expression by n-3 LC-PUFA in rats. Genes Nutr. 2013;8:589-600 pubmed 出版商